Alto Neuroscience, Inc.
ANRO
Transaktioner
63
Köp
57
Sälj
6
Nettoinsynsflöde
48.9 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
63 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-05-14 | Etkin Amit | PRESIDENT AND CEO | Sell | 400 k | 0,00 | 0 USD |
| 2026-05-14 | Etkin Amit | PRESIDENT AND CEO | Sell | 400 k | 0,00 | 0 USD |
| 2026-03-01 | Etkin Amit | PRESIDENT AND CEO | Sell | 6 k | 19,69 | 123 k USD |
| 2026-03-01 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Sell | 3 k | 19,69 | 55 k USD |
| 2026-03-01 | Etkin Amit | PRESIDENT AND CEO | Sell | 6 k | 19,69 | 123 k USD |
| 2026-03-01 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Sell | 3 k | 19,69 | 55 k USD |
| 2024-07-10 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 3 k | 13,22 | 39 k USD |
| 2024-07-10 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 3 k | 13,22 | 39 k USD |
| 2024-07-09 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 11 k | 12,53 | 134 k USD |
| 2024-07-09 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 1 k | 13,15 | 18 k USD |
| 2024-07-09 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 11 k | 12,53 | 134 k USD |
| 2024-07-09 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 1 k | 13,15 | 18 k USD |
| 2024-03-28 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 2 k | 15,80 | 25 k USD |
| 2024-03-28 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 5 k | 16,56 | 75 k USD |
| 2024-03-28 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 2 k | 15,80 | 25 k USD |
| 2024-03-28 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 5 k | 16,56 | 75 k USD |
| 2024-03-01 | Etkin Amit | PRESIDENT AND CEO | Buy | 35 k | 0,00 | 0 USD |
| 2024-03-01 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 19 k | 0,00 | 0 USD |
| 2024-03-01 | Etkin Amit | PRESIDENT AND CEO | Buy | 35 k | 0,00 | 0 USD |
| 2024-03-01 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 19 k | 0,00 | 0 USD |
| 2024-02-06 | Apeiron Investment Group Ltd. | – | Buy | 252 k | – | – |
| 2024-02-06 | Apeiron Investment Group Ltd. | – | Buy | 675 k | – | – |
| 2024-02-06 | Apeiron Investment Group Ltd. | – | Buy | 252 k | – | – |
| 2024-02-06 | Apeiron Investment Group Ltd. | – | Buy | 675 k | – | – |
| 2024-02-06 | Apeiron Investment Group Ltd. | – | Buy | 252 k | – | – |
| 2024-02-06 | Apeiron Investment Group Ltd. | – | Buy | 675 k | – | – |
| 2024-02-06 | Apeiron Investment Group Ltd. | – | Buy | 252 k | – | – |
| 2024-02-06 | Apeiron Investment Group Ltd. | – | Buy | 675 k | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 2.0 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 1.1 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 600 k | 16,00 | 9.6 mn USD |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 2.0 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 1.1 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 600 k | 16,00 | 9.6 mn USD |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 2.0 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 1.1 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 600 k | 16,00 | 9.6 mn USD |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 2.0 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 1.1 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 600 k | 16,00 | 9.6 mn USD |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 2.0 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 1.1 mn | – | – |
| 2024-02-06 | Alpha Wave Global, LP | 10% owner | Buy | 600 k | 16,00 | 9.6 mn USD |
| 2024-02-06 | Chen Po Yu (Jeff) | Director | Buy | 39 k | – | – |
| 2024-02-06 | Chen Po Yu (Jeff) | Director | Buy | 8 k | – | – |
| 2024-02-06 | Etkin Amit | PRESIDENT AND CEO | Buy | 12 k | – | – |
| 2024-02-06 | Etkin Amit | PRESIDENT AND CEO | Buy | 3 k | 16,00 | 50 k USD |
| 2024-02-06 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 8 k | – | – |
| 2024-02-06 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 17 k | 16,00 | 272 k USD |
| 2024-02-06 | Cox Christopher Nixon | Director | Buy | 589 k | – | – |
| 2024-02-06 | Cox Christopher Nixon | Director | Buy | 127 k | – | – |
| 2024-02-06 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 2 k | 16,00 | 25 k USD |
| 2024-02-06 | York Gwill | Director | Buy | 24 k | – | – |
| 2024-02-06 | Chen Po Yu (Jeff) | Director | Buy | 39 k | – | – |
| 2024-02-06 | Chen Po Yu (Jeff) | Director | Buy | 8 k | – | – |
| 2024-02-06 | Cox Christopher Nixon | Director | Buy | 589 k | – | – |
| 2024-02-06 | Cox Christopher Nixon | Director | Buy | 127 k | – | – |
| 2024-02-06 | Etkin Amit | PRESIDENT AND CEO | Buy | 12 k | – | – |
| 2024-02-06 | Etkin Amit | PRESIDENT AND CEO | Buy | 3 k | 16,00 | 50 k USD |
| 2024-02-06 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 8 k | – | – |
| 2024-02-06 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | 17 k | 16,00 | 272 k USD |
| 2024-02-06 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy | 2 k | 16,00 | 25 k USD |
| 2024-02-06 | York Gwill | Director | Buy | 24 k | – | – |